[Aseptic meningitis during treatment with high-dose intravenous immunoglobulins].
Fain
O
O
Eclache
V
V
Sitbon
M
M
Thomas
M
M
D000293:Adolescent; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D008581:Meningitis / Q000139:chemically induced*
D016756:Immunoglobulins, Intravenous
Méningite aseptique au cours d'un traitement par immunoglobulines intra-veineuses à fortes doses.